Skip to main page content
The genomic (classical and non-classical) and non-genomic actions of the ER
The cellular kinase pathways interacting with ER function (with thanks to Dr Lesley-Ann Martin)
Clinical responses according to EGFR/HER2 status in patients treated with neoadjuvant endocrine therapy.
What's this?